Guardian Pharmacy Services (NYSE:GRDN) Director William Bindley Sells 3,570,677 Shares

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director William Bindley sold 3,570,677 shares of the stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $29.68, for a total value of $105,977,693.36. Following the transaction, the director directly owned 4,469,316 shares of the company’s stock, valued at $132,649,298.88. This trade represents a 44.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Guardian Pharmacy Services Price Performance

GRDN stock opened at $37.58 on Wednesday. Guardian Pharmacy Services, Inc. has a fifty-two week low of $19.17 and a fifty-two week high of $38.12. The business’s fifty day moving average price is $32.49 and its two-hundred day moving average price is $29.83. The stock has a market capitalization of $2.38 billion, a price-to-earnings ratio of 48.81 and a beta of 0.86.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Wednesday, March 11th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.10. The firm had revenue of $397.62 million during the quarter, compared to the consensus estimate of $390.04 million. Guardian Pharmacy Services had a return on equity of 31.64% and a net margin of 3.40%.Guardian Pharmacy Services’s revenue was up 17.4% on a year-over-year basis. Research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have weighed in on GRDN. Zacks Research upgraded Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 18th. Oppenheimer lifted their price target on Guardian Pharmacy Services from $35.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, March 12th. Raymond James Financial reiterated an “outperform” rating and issued a $40.00 target price on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. UBS Group reiterated a “buy” rating on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. Finally, Stephens raised their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 14th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $38.00.

Institutional Trading of Guardian Pharmacy Services

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Ameritas Investment Partners Inc. raised its stake in Guardian Pharmacy Services by 26.5% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after buying an additional 345 shares during the last quarter. California State Teachers Retirement System increased its position in shares of Guardian Pharmacy Services by 3.4% during the 4th quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock valued at $541,000 after purchasing an additional 593 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in shares of Guardian Pharmacy Services by 7.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock worth $258,000 after purchasing an additional 805 shares during the period. Police & Firemen s Retirement System of New Jersey boosted its holdings in shares of Guardian Pharmacy Services by 20.4% in the fourth quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock worth $183,000 after buying an additional 1,028 shares during the last quarter. Finally, State of Alaska Department of Revenue purchased a new position in shares of Guardian Pharmacy Services in the third quarter worth approximately $30,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.